Effect of Epidural Steroid Injection on Bone Mineral Density in Postmenopausal Women
NCT00941473 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 28
Last updated 2024-02-20
Summary
To evaluate for the effect of corticosteroid epidural injections on bone mineral density in postmenopausal women. Candidates for the study: Post menopausal women between the ages of 55 and 80. No history of bone disease. No thyroid/parathyroid disorder. not used injected or oral steroids in the last year. No recent smoking.
The purpose is to identify any significant change in bone mineral density with the use of epidural steroid injections. This may implicate the need for patient counseling regarding this possible side effect and the possible use of preventive measures to avoid this adverse effect.
Conditions
- To Assess the Changes in Markers of Bone Turnover Over a Six Month Period After Epidural Steroid Inject
- To Assess the Changes in Bone Mineral Density
Interventions
- DRUG
-
Triamcinilone (kenalog)
Epidural steroid injection of 80mg of Triamcinilone.
Sponsors & Collaborators
-
Henry Ford Health System
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 55 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-07-31
- Primary Completion
- 2011-07-31
- Completion
- 2011-07-31
Countries
- United States
Study Locations
More Related Trials
-
Effects of Continuous Combined Hormone Replacement Therapy and Clodronate on Bone Mineral Density (BMD) in Osteoporotic Women
NCT00877097 ·Status: COMPLETED ·Phase: NA
-
Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone Mass
NCT00489424 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia Nervosa
NCT00320567 ·Status: COMPLETED ·Phase: PHASE2
-
MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)
NCT00996801 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
NCT00532207 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis
NCT01674621 ·Status: COMPLETED ·Phase: PHASE2
-
A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)
NCT00092040 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women
NCT00927186 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Investigational Drug in Osteoporosis (MK-0217-908)
NCT00092053 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density
NCT00293813 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)
NCT00092014 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Denosumab on the Pharmacokinetics of Etanercept
NCT01294397 ·Status: TERMINATED ·Phase: PHASE1
-
Combination Osteogenic Therapy in Established Osteoporosis
NCT00018447 ·Status: COMPLETED ·Phase: PHASE2
-
Determination of Adipocyte Parameters in Iliac Crest Biopsies From Post Menopausal Women
NCT00443716 ·Status: COMPLETED ·Phase: NA
-
Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss
NCT00004650 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Genistein Aglycone in Glucocorticoid Induced Osteoporosis
NCT03040531 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy of OsteoBor in Postmenopausal Osteoporosis
NCT06809816 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Multi-Center, Randomized, Open-Label Study to Assess the Immunogenicity and Safety of Denosumab in Pre-filled Syringe Compared to Vial in Subjects With Low Bone Mineral Density
NCT00515463 ·Status: COMPLETED ·Phase: PHASE3
-
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
NCT01101048 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
NCT01753856 ·Status: COMPLETED ·Phase: PHASE4
-
Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
NCT01464931 ·Status: COMPLETED ·Phase: PHASE1
-
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
NCT02157948 ·Status: COMPLETED ·Phase: PHASE3
-
Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients
NCT02156960 ·Status: UNKNOWN ·Phase: PHASE4
-
Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid
NCT00097812 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Intraarticular Steroids on Bone Turnover in Osteoarthritis
NCT00682357 ·Status: COMPLETED ·Phase: NA